Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)

SHE:002872 Revenue

Tiansheng Pharmaceutical Group had revenue of 109.22M CNY in the quarter ending September 30, 2026, a decrease of -6.34%. This brings the company's total for the last twelve months to 507.49M, down -1.68% year-over-year. In the year 2025, Tiansheng Pharmaceutical Group had annual revenue of 514.09M, down -9.76%. That makes Tiansheng Pharmaceutical Group the 24,804th largest company in the world by revenue and 4,440th in China.

• Revenue (ttm): 507.49M
• Revenue Growth: -1.68%
• P/S Ratio: 3.90
• Revenue / Employee: 398.66K
• Employees: 1,273
• Market Cap: 1.98B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Manufacturing 455.98M 88.7%
• Unallocated Other Income 40.96M 8.0%
• Pharmaceutical Distribution 17.15M 3.3%

Fiscal year ended Dec 31, 2025 See the full SHE:002872 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	514.09M	-55.63M	-9.76%
Dec 31, 2024	569.71M	-9.62M	-1.66%
Dec 31, 2023	579.33M	-27.66M	-4.56%
Jan 1, 2023	606.99M	-129.69M	-17.61%
Jan 1, 2022	736.69M	-466.06M	-38.75%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error